115
Participants
Start Date
December 15, 2021
Primary Completion Date
February 21, 2024
Study Completion Date
February 21, 2024
The Ohio State University, Columbus
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Food and Drug Administration (FDA)
FED
Ohio State University Comprehensive Cancer Center
OTHER